Immunogenicity and Efficacy of Anti-Hepatitis B Vaccines in Hemodialysis Patients
- 1 January 1992
- journal article
- a special-issue-on-virus-hepatitis-and-the-kidney
- Published by S. Karger AG in Nephron
- Vol. 61 (3) , 324-325
- https://doi.org/10.1159/000186924
Abstract
The 7-year follow-up with plasma-derived and 2-year follow-up with r-DNA vaccines have indicated the safety, immunogenicity and persistence of a vaccine-induced antibody response in hemodialysis patients. The results of our study indicate that these subjects have a lower and often inadequate immunogenic response to the HB vaccine and that the r-DNA vaccine gives a better seroconversion rate than the plasma-derived vaccines.Keywords
This publication has 0 references indexed in Scilit: